UK Pharmacogenetic & Stratified Medicine Network 12th Annual Open Meeting

UKPGx 11th Annual Open Meeting 2024 | UKPGx2024 | Part One

UKPGx 11th Annual Open Meeting 2024 | UKPGx2024 | Part Two

UKPGx 11th Annual Open Meeting 2024 | UKPGx2024 | Part Three

Getting the NHS ready for pharmacogenomics | UKPGx and AoPGBI webinar

Pharmacogenomics in the NHS: Future Prospects | Part One

Pharmacogenomics in the NHS: Future Prospects | Part Two

Polygenic risk scores and disease stratification | UKPGx2022

Genomics England - Looking to the future | UKPGx2022

Insights from the metabolome in UK Biobank | UKPGx2022

Proteomics in the era of large scale biobanks | UKPGx2022

Human Cell Atlas and its relevance to precision medicine | UKPGx2022

UK Biobank - A unique combination of scale, depth, duration & accessibility | UKPGx2022

Making healthcare personal - The growing role of genomics and microbiome innovation | UKPGx2022

Can we integrate pharmacogenetics in Our Future Health? | UKPGx2022

Pharmacogenomics in sub-Saharan Africans | UKPGx2022

Pharmacogenomics implementation - the RCP-BPS report | UKPGx2022

Microbiome in drug response - Navigating the genetic landscape of the E. coli pangenome | UKPGx2022

Modelling a two-stage screen for autosomal dominant familial hypercholesterolemia (FH) | UKPGx2022

UKPGx2021 Hybrid - Sessions and Speakers

Welcome to the 8th Annual Open Meeting of the UK Pharmacogenetics & Stratified Medicine Network

First reflections on the UK response to COVID-19

COVID-19 and beyond - a new era in UK regulation?

Genetics and genomics in drug discovery

Using Mendelian randomisation to evaluate the effect of long term HMG CoA reductase inhibition

Using transcriptomic profiling to stratify sepsis patients

How age and sex shape the biology of skin cancer

Vaccine development as part of pandemic preparedness

In pursuit of actionable information derived from SARS-CoV-2 genomes

Treatable traits in COVID-19

Precision medicine and metabolic bone disease - fact or fantasy?

Transforming healthcare with artificial intelligence - lessons from ophthalmology

Precision medicine - what is the future?

Summary of group discussions

NHS pathway for Long COVID

Medicine development for multimorbitities

What is Long Covid?

Finding therapies for post acute COVID - the HEAL COVID platform trial

Neurological complications of COVID

UKPGx2021Sessions

Summary of group discussions - Rapporteurs

Genome-wide polygenic risk scores and PCSK9 inhibition with Alirocumab

Clinical utility of PRS

Genomic profiling for prediction of Alzheimer's disease risk

Precision Public Health

Prioritisation of cancer therapeutic targets using CRISPR Cas9 screens

Somatic and germline genome editing promises, perils and pipedreams

Gene therapy in haemophilia

Pulmonary arterial hypertension - Molecular stratification of a rare disease

Welcome to the 7th Annual Open Meeting of the UK Pharmacogenetics & Stratified Medicine Network

UKPGx Open Meetings Feedback

Rapporteurs

Prospects and challenges for future knockout discovery and characterisation

How can loss of function mutations inform drug discovery

Drug Targets, druggability, and efficacy

Human Knockouts in population ascertained adults with related parents

Opportunities for human knockout research and discovery using the Genomics England dataset

Pharmacogenomics in the 100,000 Genomes Project

100,000 Genomes Project and the NHS Genomic Medicine Service

Pharmacogenomics in Primary Care